Liminal BioSciences

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LMNL and other ETFs, options, and stocks.

About LMNL

Liminal BioSciences, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using drug discovery platform and a data driven approach. 

CEO
Bruce Philip Pritchard
CEOBruce Philip Pritchard
Employees
48
Employees48
Headquarters
Laval, Québec
HeadquartersLaval, Québec
Founded
1994
Founded1994
Employees
48
Employees48

LMNL Key Statistics

Market cap
13.89M
Market cap13.89M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
29.56K
Average volume29.56K
High today
$0.45
High today$0.45
Low today
$0.40
Low today$0.40
Open price
$0.44
Open price$0.44
Volume
38.59K
Volume38.59K
52 Week high
$2.60
52 Week high$2.60
52 Week low
$0.3652
52 Week low$0.3652

LMNL Earnings

-$1.25
-$0.83
-$0.42
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, After Hours
ActualExpected Nov 14, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.